Clinical Trial Update: 11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial is evaluating 11C-Metomidate PET/CT imaging in Phase 2/3 to assess endocrine hypertension and characterize adrenal tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Tumors
• Aldosterone-producing Adenoma
• Aldosteronism

Drugs mentioned

• 11C-Metomidate

Snippet

Sponsor: Changi General Hospital | Conditions: Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING